TRICARICO, Domenico
 Distribuzione geografica
Continente #
NA - Nord America 8.402
AS - Asia 3.058
EU - Europa 2.270
SA - Sud America 788
AF - Africa 99
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 14.625
Nazione #
US - Stati Uniti d'America 8.293
SG - Singapore 1.280
CN - Cina 871
BR - Brasile 682
SE - Svezia 438
HK - Hong Kong 404
IT - Italia 391
RU - Federazione Russa 359
DE - Germania 252
UA - Ucraina 201
VN - Vietnam 186
GB - Regno Unito 183
FI - Finlandia 159
FR - Francia 100
IN - India 72
CA - Canada 66
CI - Costa d'Avorio 46
BD - Bangladesh 42
AR - Argentina 41
ID - Indonesia 37
BE - Belgio 31
PL - Polonia 27
MX - Messico 25
ES - Italia 23
IQ - Iraq 23
EC - Ecuador 20
TR - Turchia 20
ZA - Sudafrica 20
IE - Irlanda 18
JP - Giappone 17
NL - Olanda 17
CZ - Repubblica Ceca 13
AT - Austria 12
PK - Pakistan 12
LT - Lituania 11
VE - Venezuela 11
KR - Corea 10
CL - Cile 9
CO - Colombia 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
IR - Iran 7
TW - Taiwan 7
BA - Bosnia-Erzegovina 6
NP - Nepal 6
RS - Serbia 6
TN - Tunisia 6
AZ - Azerbaigian 5
EG - Egitto 5
IL - Israele 5
JO - Giordania 5
KZ - Kazakistan 5
MA - Marocco 5
PY - Paraguay 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
DZ - Algeria 4
HN - Honduras 4
KE - Kenya 4
PE - Perù 4
BO - Bolivia 3
DK - Danimarca 3
KW - Kuwait 3
NO - Norvegia 3
PA - Panama 3
RO - Romania 3
SN - Senegal 3
A1 - Anonimo 2
BG - Bulgaria 2
BH - Bahrain 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
GD - Grenada 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
NG - Nigeria 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CD - Congo 1
CR - Costa Rica 1
DM - Dominica 1
EU - Europa 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
Totale 14.617
Città #
Fairfield 1.017
Ashburn 814
Woodbridge 781
Chandler 701
Singapore 667
Seattle 439
Jacksonville 436
Houston 427
Hong Kong 394
Ann Arbor 382
Cambridge 366
Nyköping 356
Wilmington 333
Beijing 269
Dallas 190
Bari 159
Roxbury 142
Lawrence 141
Nanjing 135
Los Angeles 134
New York 101
Des Moines 92
Princeton 84
Boardman 75
Ho Chi Minh City 68
Inglewood 67
São Paulo 56
London 51
San Diego 51
Abidjan 46
Helsinki 45
Santa Clara 42
Shenyang 40
Chicago 39
Munich 39
Brooklyn 38
Buffalo 35
Nanchang 33
Brussels 31
Dong Ket 30
Frankfurt am Main 30
Jakarta 30
Jiaxing 28
Rio de Janeiro 28
Moscow 27
Shanghai 26
Changsha 25
Tianjin 25
Hanoi 24
Warsaw 23
Montreal 22
San Francisco 22
Belo Horizonte 21
Hebei 19
Toronto 18
Dublin 17
Guangzhou 17
Denver 16
Poplar 16
Atlanta 15
Dearborn 15
Johannesburg 15
Milan 15
Phoenix 15
Redwood City 15
Brasília 14
Rome 14
Dhaka 13
Stockholm 13
The Dalles 13
Tokyo 13
Zhengzhou 13
Brno 12
Council Bluffs 12
Norwalk 12
Nuremberg 12
Paris 12
Pune 12
Manchester 11
Orem 11
York 11
Campinas 10
Columbus 10
Jinan 10
Wuhan 10
Baghdad 9
Mumbai 9
Ningbo 9
Porto Alegre 9
Washington 9
Chennai 8
Düsseldorf 8
Guarulhos 8
Haiphong 8
Indiana 8
Ribeirão Preto 8
Sannicandro di Bari 8
Seoul 8
Bitetto 7
Charlotte 7
Totale 10.231
Nome #
A novel injectable formulation of 6-Fluoro-L-DOPA imaging agent for diagnosis of neuroendocrine tumors and Parkinson’s disease 207
ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force 204
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 195
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 185
Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options 183
Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis 167
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 164
Acetazolamide prevents vacuolar myopathy in skeletal muscle of K+-depleted rats 161
Carbonic anhydrase inhibitors ameliorate the symptoms of hypokalaemic periodic paralysis in rats by opening the muscular Ca2+-activated-K+ channels 160
Cell Cycle Regulation by Ca2+-Activated K+ (BK) Channels Modulators in SH-SY5Y Neuroblastoma Cells 157
Antiproliferative effects of neuroprotective drugs targeting big Ca2+-activated K+ (BK) channel in the undifferentiated neuroblastoma cells 156
New Azepino[4,3-b]indole derivatives as nanomolar selective inhibitors of human butyrylcholinesterase showing protective effects against NMDA-induced neurotoxicity 152
Zoledronic acid modulation of TRPV1 channel currents in osteoblast cell line and native rat and mouse bone marrow-derived osteoblasts: Cell proliferation and mineralization effect 152
Recent advances in the pathogenesis and drug action in periodic paralyses and related channelopathies 151
Acetazolamide opens the muscular KCa2+ channel: a novel mechanism of action that may explain the therapeutic effect of the drug in the hypokalemic periodic paralysis 149
Alginate-Based Hydrogel Containing Minoxidil/Hydroxypropyl-β-Cyclodextrin Inclusion Complex for Topical Alopecia Treatment 148
Acetazolamide opens the muscular K(Ca)2+ channel: A novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis 146
Risk of myopathy in patients in therapy with statins: Identification of biological markers in a pilot study 146
Reduced expression of Kir6.2/SUR2A subunits explains KATP deficiency in K+-depleted rats 144
Aging and chloride channel regulation in rat fast-twitch muscle fibres 141
Bridging repair of the abdominal wall in a rat experimental model. Comparison between uncoated and polyethylene oxide-coated equine pericardium meshes 134
Calcium-Activated K Channel Regulates Cell Viability in Hyperkalemic and Hypokalemic Conditions: Implication in the Neuromuscular Disoders 131
Effects of clofibric acid analogs on chloride channel conductance of rat skeletal muscle 131
The biophysical and pharmacological characteristics of skeletal muscle ATP-Sensitive K+ channels are modified in K+-depleted rat, an animal model of hypokalemic periodic paralysis 129
Molecular modeling of antibodies for the treatment of TNFα-related immunological diseases 128
Changes of chloride channel regulation in rat skeletal muscle during aging 126
Nerve growth factor, brain-derived neurotrophic factor and osteocalcin gene relationship in energy regulation, bone homeostasis and reproductive organs analyzed by mrna quantitative evaluation and linear correlation analysis 126
The large conductance Ca2+ -activated K+ (BKCa) channel regulates cell proliferation in SH-SY5Y neuroblastoma cells by activating the staurosporine-sensitive protein kinases 126
Oxytocin/Osteocalcin/IL-6 and NGF/BDNF mRNA Levels in Response to Cold Stress Challenge in Mice: Possible Oxytonic Brain-Bone-Muscle-Interaction 126
The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia 125
Molecular structure and function of big calcium-activated potassium channels in skeletal muscle: Pharmacological perspectives 125
Antimyotonic actions of new chiral sodium channel, blockers 124
Accelerated infliximab infusion: Safety, factors predicting adverse events, patients' satisfaction and cost analysis. A cohort study in IBD patients 122
Pharmaceutical development of novel lactate-based 6-fluoro-L-DOPA formulations 122
Thymidine Phosphorylase Expression and Microvascular Density Correlation Analysis in Canine Mammary Tumor: Possible Prognostic Factor in Breast Cancer 122
Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+ - deficient rats 120
Staurosporine Blocks the ATP-Sensitive K+ Channels and Induces Atrophy in Rodent Skeletal Muscles 119
Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery 115
Splicing of the rSlo gene affects the molecular composition and drug response of Ca2+-activated K+ channels in skeletal muscle 115
Carboxylic acids and chloride conductance in skeletal muscle: influence on the pharmacological activity induced by the chain substituents and the distance between the phenolic group and the carboxylic function in 4-chloro-phenoxy alkanoic acids 114
Atrophy and phenotype transition signaling exert opposite actions on the KATP channels of disused rat soleus muscle 113
Ion channels in muscle and cardiac hereditary diseases: from gene dysfunction to pharmacological therapy 113
Molecular determinants for the activating/blocking actions of the 2H-1,4-benzoxazine derivatives, a class of potassium channel modulators targeting the skeletal muscle KATP channels 113
Taurine and skeletal muscle ion channels 112
A new benzoxazine compound blocks KATP channels in pancreatic beta cells: molecular basis for tissue selectivity in vitro and hypoglycaemic action in vivo 112
Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type-dependent biophysical and pharmacological properties 111
Pharmacovigilance database search discloses ClC-K channels as a novel target of the AT1 receptor blockers valsartan and olmesartan 111
Single-dose extended-toxicity preclinical study on novel radiotracer formulations for use in the diagnosis of neuroendocrine tumor and neurodegenerative disorders 110
Involvement of K(Ca2+)channels in the local abnormalities and hyperkalemia following the ischemia-reperfusion injury of rat skeletal muscle 109
Cold stress in mice requires Nerve Growth Factor activity in brown fat and increases Osteocalcin expression in bone 109
Effects of Acetazolamide on alpha subunit of human BK channel expressed in HEK293 cells 108
Commentary: A BK (Slo1) channel journey from molecule to physiology. 108
Different sulfonylurea and ATP sensitivity characterizes the juvenile and the adult form of K-ATP channel complex of rat skeletal muscle 107
Dual response of the KATP channels to staurosporine: a novel role of SUR2B, SUR1 and Kir6.2 subunits in the regulation of the atrophy in different skeletal muscle phenotypes 107
Calcium homeostasis is altered in skeletal muscle of spontaneously hypertensive rats cytofluorimetric and gene expression analysis 106
Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides-induced atrophy in skeletal muscle 105
Effects of high energy phosphates and l-arginine on the electrical parameters of ischemic-reperfused rat skeletal muscle fibers 104
Effects of mexiletine on ATP sensitive K+ channel of rat skeletal muscle fibres: a state dependent mechanism of action 101
Involvement of 3Na+/2K+ ATP-ase and Pi-3 kinase in the response of skeletal muscle ATP-sensitive K+ channels to insulin 101
Developmental changes of membrane electrical properties of rat skeletal muscle fibers produced by prenatal exposure to carbon monoxide 101
Taurine and skeletal muscle disorders 98
Dualistic actions of cromakalim and new potent 2H-1,4-benzoxazine derivatives on the native skeletal muscle K(ATP) channel 98
Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis 97
ALTERATIONS OF ELECTRICAL AND BIOCHEMICAL PARAMETERS OF ISCHEMIC AND REPERFUSED RAT SKELETAL-MUSCLE FIBERS 96
Insulin modulation of ATP-sensitive K+ channel of rat skeletal muscle is impaired in the hypokalaemic state 96
Taurine blocks ATP-sensitive potassium channels of rat skeletal muscle fibres interfering with the sulphonylurea receptor 96
Stereospecific effects of tocainide and its chiral derivatives on rat skeletal muscle sodium channel. 96
Expression profile of NGF-BDNF and Osteocalcin genes in brain, bone, fat stores and reproductive organs 96
Osteocalcin interacts with Brain-derived Neurotrophic Factor, Nerve Growth Factor but not Oxytocin in the regulation of bone, energy, brain and reproductive functions. 96
Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms. 96
Biophysical changes of skeletal muscle K-ATP channels in K+ depleted rats and pharmacological interventions. 95
Cysteine restores the activity of ATP-sensitive potassium channels of skeletal muscle fibers of aged rats 95
Approccio multi-target alla terapia medica dell’ipertrofia prostatica benigna 94
Phenotype-dependent functional and pharmacological properties of BK channels in skeletal muscle: Effects of microgravity 94
Effects of taurine analogues on chloride channel conductance of rat skeletal muscle fibers: a structure-activity relationship investigation 93
Drugs targeting the metabolically regulated ATP-sensitive potassium channels and big calcium-activated potassium channels in skeletal muscles: Pharmacological perspectives and therapeutic use 92
ATP-sensitive K+ channels of skeletal muscle fibers from young adult and aged rats: Possible involvement of thiol-dependent redox mechanisms in the age-related modifications of their biophysical and pharmacological properties 92
An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function 91
null 90
The KATP channel is a molecular sensor of atrophy in skeletal muscle 89
A stereospecific bindings site regulates the Cl- ion channel in rat skeletal muscle 89
Stereoselective interaction of tocainide and its chiral analogs with the sodium channels in human myoballs 88
Zoledronic acid as a novel dual blocker of KIR6.1/2-SUR2 subunits of ATP-sensitive K+ channels: Role in the adverse drug reactions 88
Taurine and skeletal muscle ion channels 87
Experimental evaluation of the effects of pravastatin on electrophysiological parameters of rat skeletal muscle 87
null 86
ATP-DEPENDENT EFFECTS OF CROMAKALIM AND OF NEW SYNTHESIZED BENZOXAZINE DERIVATIVES ON MUSCLE KATP CHANNEL. 86
ATP-sensitive Potassium Channel Subunits in Neuroinflammation: Novel Drug Targets in Neurodegenerative Disorders 86
MODULATION OF RAT SKELETAL MUSCLE CHLORIDE CHANNELS BY ACTIVATORS AND INHIBITORS OF PROTEIN KINASE C 85
Therapeutic approaches to ion channel diseases 85
Effects of the antidiabetic drugs on the age-related atrophy and sarcopenia associated with diabetes type II 85
PYRIMIDIN 3-OXIDE COMPOUNDS SUITABLE FOR THE TREATMENT OF PATHOLOGIES OF THE SKELETAL MUSCLE, IN PARTICULAR FOR THE TREATMENT OF THE HYPOKALEMIC PARALYSIS 84
Biophysical and pharmacological characterization of K-ATP and BK channels of slow and fast rat skeletal muscle fibers 84
NGF-BDNF-Osteocalcin and oxytocin gene interaction in brain, bone, fat stores and reproductive organs 84
Enantiomeric pairs of clofibric acid analogs produce opposite effects on chloride channel conductance in rat skeletal muscle 84
Pathophysiological Consequences of KATP Channel Overactivity and Pharmacological Response to Glibenclamide in Skeletal Muscle of a Murine Model of Cantù Syndrome 84
Consequences of SUR2[A478V] Mutation in Skeletal Muscle of Murine Model of Cantu Syndrome 83
Evaluation of short and long term cold stress challenge of nerve grow factor, brain-derived neurotrophic factor, osteocalcin and oxytocin mRNA expression in BAT, brain, bone and reproductive tissue of male mice using real-time PCR and linear correlation analysis 82
Effects of Pleiotrophin Overexpression on Mouse Skeletal Muscles in Normal Loading and in Actual and Simulated Microgravity 81
Oxtr/TRPV1 expression and acclimation of skeletal muscle to cold-stress in male mice 81
Totale 11.498
Categoria #
all - tutte 66.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021766 0 0 0 0 0 40 112 73 140 193 114 94
2021/20221.162 39 190 13 58 46 64 65 50 114 76 160 287
2022/20231.832 257 196 131 175 227 232 20 201 292 14 52 35
2023/2024692 36 122 41 60 99 133 14 40 25 27 18 77
2024/20252.631 104 45 178 97 88 220 257 276 109 135 353 769
2025/20262.972 773 298 401 564 689 247 0 0 0 0 0 0
Totale 14.960